ANTITUSSIVE PROPERTIES OF BUTORPHANOLCAVANAGH RL; GYLYS JA; BIERWAGEN ME et al.1976; ARCH. INTERNATION. PHARMACODYN. THERAP.; BELG.; DA. 1976; VOL. 220; NO 2; PP. 258-268; BIBL. 12 REF.Article

ANALGESICSWHITE A.1971; REP. PROGR. APPL. CHEM.; G.B.; DA. 1971; VOL. 56; PP. 711-725; BIBL. 3 P.Serial Issue

THE PHARMACOLOGY OF BUTORPHANOL A 3,14-DIHYDROXYMORPHINAN NARCOTIC ANTAGONIST ANALGESICPIRCIO AW; GYLYS JA; CAVANAGH RL et al.1976; ARCH. INTERNATION. PHARMACODYN. THERAP.; BELG.; DA. 1976; VOL. 220; NO 2; PP. 231-257; BIBL. 34 REF.Article

TOTAL SYNTHESIS OF 3,14-DIHYDROXYISOMORPHINANS AND 9ALPHA -HYDROXY-3-METHOXYHASUBANANSBELLEAU B; WONG H; MONKOVIC I et al.1974; J. CHEM. SOC., CHEM. COMMUNIC.; G.B.; DA. 1974; NO 15; PP. 603-604; BIBL. 4 REF.Article

BIOTRANSFORMATION OF THEBAINE BY CELL SUSPENSION CULTURES OF PAPAVER SOMNIFERUM CV. MARIANNE = BIOTRANSFORMATION DE LA THEBAINE PAR DES CULTURES CELLULAIRES EN SUSPENSION DE P.S. CV. M.TAM WHJ; KURZ WGW; CONSTABEL F et al.1982; PHYTOCHEMISTRY; ISSN 0031-9422; USA; DA. 1982; VOL. 21; NO 1; PP. 253-254; BIBL. 4 REF.Article

ABNORMAL OSMIUM TETROXIDE OXIDATION OF N-METHYLMORPHINAN DERIVATIVESSAWA YK; MAEDA S; ADACHI M et al.1975; TETRAHEDRON; G.B.; DA. 1975; VOL. 31; NO 8; PP. 953-956; BIBL. 2 REF.Article

(-)-2-HYDROXY-NACYCLOPROPYLMETHYLMORPHINAN: RADIOIMMUNUASSAY AND PHARMACOKINETIC PROFILEDIXON R; YOUNG R; MOHACSI E et al.1978; CLIN. PHARMACOL. THERAPEUT.; USA; DA. 1978; VOL. 24; NO 5; PP. 622-627; BIBL. 5 REF.Article

ALKALOIDS OF OCOTEA BRACHYBOTRA.VECCHIETTI V; CASAGRANDE C; FERRARI G et al.1977; FARMACO, ED. SCI.; ITAL.; DA. 1977; VOL. 32; NO 11; PP. 767-779; ABS. ITAL.; BIBL. 19 REF.Article

SYNTHETIC MORPHINANS AND HASUBANANS. VI. TOTAL SYNTHESIS OF 3-HYDROXYISOMORPHINANS, 3-HYDROXYHASUBANANS, AND 3,9-DIHYDROXYHASUBANANSMONKOVIC I; WONG H.1976; CANAD. J. CHEM.; CANADA; DA. 1976; VOL. 54; NO 6; PP. 883-891; ABS. FR.; BIBL. 19 REF.Article

ISOLATION, X-RAY ANALYSIS AND SYNTHESIS OF A METABOLITE OF (-)-2-HYDROXY-N-ALLYLMORPHINANBLOUNT JF; MOHACSI E; VANE FM et al.1973; J. MEDICIN. CHEM.; U.S.A.; DA. 1973; VOL. 16; NO 4; PP. 352-355; BIBL. 13 REF.Serial Issue

EFFECT OF THE POSITION OF THE PHENOLIC GROUP IN MORPHINANS ON THEIR AFFINITY FOR OPIATE RECEPTOR BINDINGSIMON LD; SIMON FR; MOHASCI E et al.1981; LIFE SCI. (1973); ISSN 0024-3205; GBR; DA. 1981; VOL. 28; NO 24; PP. 2769-2772; BIBL. 9 REF.Article

BIOTRANSFORMATION OF (RS)-RETICULINE AND MORPHINAN ALKALOIDS BY CELL CULTURES OF PAPAVER SOMNIFERUM.FURUYA T; NAKANO M; YOSHIKAWA T et al.1978; PHYTOCHEMISTRY; G.B.; DA. 1978; VOL. 17; NO 5; PP. 891-893; BIBL. 18 REF.Article

HydromorphoneMURRAY, Alison; HAGEN, Neil A.Journal of pain and symptom management. 2005, Vol 29, Num 5S, pp S57-S66, issn 0885-3924, SUPConference Paper

The status of naltrexone in the treatment of alcohol dependence : Specific effects on heavy drinkingPETTINATI, Helen M; O'BRIEN, Charles P; RABINOWITZ, Amanda R et al.Journal of clinical psychopharmacology. 2006, Vol 26, Num 6, pp 610-625, issn 0271-0749, 16 p.Article

An open trial of naltrexone in the treatment of depersonalization disorderSIMEON, Daphne; KNUTELSKA, Margaret.Journal of clinical psychopharmacology. 2005, Vol 25, Num 3, pp 267-270, issn 0271-0749, 4 p.Article

Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophreniaPETRAKIS, Ismene L; O'MALLEY, Stephanie; ROUNSAVILLE, Bruce et al.Psychopharmacologia. 2004, Vol 172, Num 3, pp 291-297, issn 0033-3158, 7 p.Article

A 6-month controlled naltrexone study: Combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependenceBALLDIN, J; BERGLUND, M; WILLANDER, A et al.Alcoholism, clinical and experimental research. 2003, Vol 27, Num 7, pp 1142-1149, issn 0145-6008, 8 p.Article

New therapeutic options for alcohol dependence : Long-acting intramuscular formulations of naltrexoneGARBUTT, James C.The Journal of clinical psychiatry. 2006, Vol 67, pp 30-34, issn 0160-6689, 5 p., SUP14Article

Antidotes : benefits and risksPROUDFOOT, A. T.Toxicology letters. 1995, Vol 82-83, pp 779-783, issn 0378-4274Conference Paper

NaloxoneLa Revue Prescrire. 1995, Vol 15, Num 156, issn 0247-7750, p. 741Article

Morphine and codeine from mammalian brainWEITZ, C. J; LOWNEY, L. I; FAULL, K. F et al.Proceedings of the National Academy of Sciences of the United States of America. 1986, Vol 83, Num 24, pp 9784-9788, issn 0027-8424Article

ALKALOIDS FROM PAPAVER ARMENIACUM, P. FUGAX AND P. TAURICOLAPHILLIPSON JD; THOMAS OO; GRAY AI et al.1981; PLANTA MED.; ISSN 0032-0943; DEU; DA. 1981; VOL. 41; NO 2; PP. 105-118; BIBL. 37 REF.Article

6BETA -(N,N-BIS(2-CHLOROETHYL)AMINO)-17-(CYCLOPROPYLMETHYL)-4,5ALPHA -EPOXY-3,14-DIHYDROXYMORPHINAN (CHLORANALTREXAMINE), A POTENT OPIOID RECEPTOR ALKYLATING AGENTS WITH ULTRALONG NARCOTIC ANTAGONIST ACTIVITY.PORTOGHESE PS; LARSON DL; JIANG JB et al.1978; J. MEDICIN. CHEM.; USA; DA. 1978; VOL. 21; NO 7; PP. 598-599; BIBL. 23 REF.Article

INTERACTIONS OF NARCOTICS AND THEIR ANTAGONISTS WITH HUMAN SERUM ESTERASE. IX: STRUCTURE-ACTIVITY RELATIONSHIPS OF MORPHINANS AND MORPHINESBAMBERGER MJ; GERO A.1981; ARCH. INT. PHARMACODYN. THER.; ISSN 0003-9780; BEL; DA. 1981; VOL. 249; NO 2; PP. 189-202; BIBL. 14 REF.Article

THE DEMETHYLATION OF 1,2,3,4,5,6,7,8-OCTAHYDRO-1-(2-METHOXYBENZYL)-2-METHYLISOQUINOLINE. THE SYNTHESIS OF 1-HYDROXY-N-METHYLMORPHINAN AND 1,2,3,4,4A,5,6,7,7A,8-DECAHYDRO-7-METHYL (1) BENZOPYRANO (2,3-J) ISOQUINOLINEWITTEKIND RR; CAPIRIS T; LAZARUS S et al.1972; J. HETEROCYCL. CHEM.; U.S.A.; DA. 1972; VOL. 9; NO 6; PP. 1441-1444; BIBL. 14 REF.Serial Issue